Drug intelligence / Profile preview

Innovo Immune Newcastle Vaccine

Development stage
Unknown
Lead developer
Virogen Biotechnology
Modality
Vaccines & Immunotherapeutics
Administration
In Ovo, Subcutaneous
01

Overview

Innovo Immune Newcastle Vaccine is a veterinary vaccine developed by Virogen, Inc. to protect poultry against Newcastle disease, a highly contagious and often fatal viral infection. The vaccine is designed to elicit a protective immune response, thereby reducing mortality and preventing the severe tissue lesions characteristic of the disease in chickens and other susceptible birds. Virogen, a Minnesota-based corporation, holds the patent for the vaccine and has secured European Union manufacturing approval and licensing. The product is commercialized internationally, with established distribution networks and purchase orders in Asian and Middle Eastern markets.

Brand names
Innovo Immune Newcastle VaccineInnovo Newcastle Vaccine
Other names
Newcastle disease vaccine
02

Targets

TLR4 (Toll-like receptor 4)MHC I (MHC class I})

Beyond the preview

Go deeper on Innovo Immune Newcastle Vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovo Immune Newcastle Vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call